Quick Answer
Beam Therapeutics Inc. reported Total Assets of $1.48 billion for fiscal year 2025.
Beam Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.48B | +34.2% |
| 2024 | $1.10B | -24.4% |
| 2023 | $1.46B | +8.8% |
| 2022 | $1.34B | -9.0% |
| 2021 | $1.47B | +226.4% |
| 2020 | $451.68M | +189.4% |
| 2019 | $156.10M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.31B | +11.9% | -5.8% |
| June 30, 2025 | $1.39B | +10.3% | -5.2% |
| March 31, 2025 | $1.47B | +7.9% | +32.9% |
| December 31, 2024 | $1.10B | -24.4% | -5.8% |
| September 30, 2024 | $1.17B | -9.2% | -7.1% |
| June 30, 2024 | $1.26B | -6.8% | -7.2% |
| March 31, 2024 | $1.36B | +2.1% | -6.8% |
| December 31, 2023 | $1.46B | +8.8% | +13.1% |
- Beam Therapeutics Inc. showed an increase of +34.2% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Beam Therapeutics Inc.’s total assets has grown by 848.9% (from $156.10 million to $1.48 billion).
- The most recent figure is from Beam Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: